Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Zenith Drugs Ltd. Share Price
Day's Range
Day's Range
Low
₹39.80
High
₹43.25
Price Summary
| Previous Close | ₹40.70 |
|---|---|
| Day's Range | ₹39.80 - ₹43.25 |
| Open | ₹42.90 |
| 52 Week Range | ₹33.30 - ₹84.65 |
| Volume | 17,600 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 7.16 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 7.68 |
| TTM EPS (₹) | 5.59 |
| P/E Ratio | 11.21 |
| Book Value(₹) | 1.18 |
| PAT Margin (%) | 6.42 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 25.15 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | N/A | 1316.2 |
| Expenses | N/A | N/A |
| PBT | N/A | 132.93 |
| Operating profit | N/A | 0.0 |
| Net profit | N/A | 95.37 |
About Zenith Drugs Ltd.
| Founded | 2000 |
|---|---|
| Managing Director | Sandeep Bhardwaj |
| NSE Symbol | ZENITHDRUG |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,40,134.01 | 1,847.30 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,77,883.86 | 6,708.90 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,47,526.68 | 4,376.45 | 3,101.60 - 3,101.60 |
| Apollo Hospitals Enterprise Ltd. | 1,12,696.26 | 8,094.85 | 6,677.50 - 6,677.50 |
| Lupin Ltd. | 1,12,463.67 | 2,377.90 | 1,836.80 - 1,836.80 |
| Cipla Ltd. | 1,10,088.66 | 1,347.70 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,09,072.97 | 1,293.00 | 1,138.50 - 1,138.50 |
| Max Healthcare Institute Ltd. | 98,793.98 | 1,012.45 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 98,063.24 | 2,427.15 | 1,909.70 - 1,909.70 |
| Zydus Lifesciences Ltd. | 94,596.06 | 938.00 | 835.50 - 835.50 |
No Records Found
Latest News
Pharmaids Pharmaceuticals informs about compliance report
Mercury Laboratories informs about press release
Rainbow Children's Medicare informs about update on ongoing tax litigation
Emcure Pharmaceuticals informs about ESG rating
Laurus Labs informs about newspaper advertisements
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Laurus Labs has informed that it enclosed copies of the newspaper advertisements pertaining to Notice to Shareholders with respect to, ‘Submission of TDS related documents for 2nd Interim Dividend for FY 2025-26’. The advertisements were published in ‘Business Standard’ (English) and ‘Prajasakti’ (Telugu) on May 07, 2026.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Zenith Drugs Ltd. is ₹40.70 as of 2026-05-08.
The market capitalisation of Zenith Drugs Ltd. is ₹73.65 as of 2026-05-07.
The 1-year return of Zenith Drugs Ltd. is 0.00% as of 2026-05-08.
The P/E ratio of Zenith Drugs Ltd. is 17.17 as of 2026-05-08.
The 52-week high and low of Zenith Drugs Ltd. are ₹84.65 and ₹33.30, respectively, as of 2026-05-08.
Disclaimer
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
